CA2703458A1 - Phenylpyrrolidine compounds - Google Patents

Phenylpyrrolidine compounds Download PDF

Info

Publication number
CA2703458A1
CA2703458A1 CA2703458A CA2703458A CA2703458A1 CA 2703458 A1 CA2703458 A1 CA 2703458A1 CA 2703458 A CA2703458 A CA 2703458A CA 2703458 A CA2703458 A CA 2703458A CA 2703458 A1 CA2703458 A1 CA 2703458A1
Authority
CA
Canada
Prior art keywords
disorders
methoxy
pyrrolidin
phenyl
insomnia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2703458A
Other languages
English (en)
French (fr)
Inventor
Jose Falcó
Albert Palomer
Antonio Guglietta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2703458A1 publication Critical patent/CA2703458A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/14—Nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Emergency Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2703458A 2007-10-25 2008-10-23 Phenylpyrrolidine compounds Abandoned CA2703458A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200702800 2007-10-25
ES200702800A ES2331276B1 (es) 2007-10-25 2007-10-25 Compuestos de fenilpirrolidina.
PCT/EP2008/064390 WO2009053441A1 (en) 2007-10-25 2008-10-23 Phenylpyrrolidine compounds

Publications (1)

Publication Number Publication Date
CA2703458A1 true CA2703458A1 (en) 2009-04-30

Family

ID=40291255

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2703458A Abandoned CA2703458A1 (en) 2007-10-25 2008-10-23 Phenylpyrrolidine compounds

Country Status (21)

Country Link
US (1) US20120184594A1 (cg-RX-API-DMAC7.html)
EP (1) EP2203422B1 (cg-RX-API-DMAC7.html)
JP (1) JP2011500764A (cg-RX-API-DMAC7.html)
KR (1) KR20100072287A (cg-RX-API-DMAC7.html)
CN (1) CN101878198A (cg-RX-API-DMAC7.html)
AR (1) AR069002A1 (cg-RX-API-DMAC7.html)
AT (1) ATE513809T1 (cg-RX-API-DMAC7.html)
AU (1) AU2008316473A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0817660A2 (cg-RX-API-DMAC7.html)
CA (1) CA2703458A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008003141A1 (cg-RX-API-DMAC7.html)
DK (1) DK2203422T3 (cg-RX-API-DMAC7.html)
ES (2) ES2331276B1 (cg-RX-API-DMAC7.html)
MX (1) MX2010004469A (cg-RX-API-DMAC7.html)
PL (1) PL2203422T3 (cg-RX-API-DMAC7.html)
PT (1) PT2203422E (cg-RX-API-DMAC7.html)
RU (1) RU2010120845A (cg-RX-API-DMAC7.html)
SI (1) SI2203422T1 (cg-RX-API-DMAC7.html)
TW (1) TW200920353A (cg-RX-API-DMAC7.html)
UY (1) UY31425A1 (cg-RX-API-DMAC7.html)
WO (1) WO2009053441A1 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
PT1189900E (pt) * 1999-06-30 2004-05-31 Bristol Myers Squibb Co Derivados de aminopirrolidina heterociclicos utilizados como agentes melatonergicos

Also Published As

Publication number Publication date
BRPI0817660A2 (pt) 2015-09-29
PT2203422E (pt) 2011-09-26
AR069002A1 (es) 2009-12-23
TW200920353A (en) 2009-05-16
CN101878198A (zh) 2010-11-03
JP2011500764A (ja) 2011-01-06
UY31425A1 (es) 2009-04-30
SI2203422T1 (sl) 2011-10-28
EP2203422B1 (en) 2011-06-22
PL2203422T3 (pl) 2011-11-30
AU2008316473A1 (en) 2009-04-30
DK2203422T3 (da) 2011-10-10
MX2010004469A (es) 2010-07-06
ES2331276A1 (es) 2009-12-28
RU2010120845A (ru) 2011-11-27
ES2368697T3 (es) 2011-11-21
WO2009053441A1 (en) 2009-04-30
CL2008003141A1 (es) 2009-03-06
KR20100072287A (ko) 2010-06-30
US20120184594A1 (en) 2012-07-19
ATE513809T1 (de) 2011-07-15
ES2331276B1 (es) 2010-10-21
EP2203422A1 (en) 2010-07-07

Similar Documents

Publication Publication Date Title
AU2009275918A1 (en) 1,6-dihydro-2H-3-oxa-6-aza-as-indacene compounds
US20110112148A1 (en) Indoline compounds
US20120059053A1 (en) Compounds of 2,3-dihydro-benzofuran
EP2443108A1 (en) 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
EP2203422B1 (en) Phenylpyrrolidine compounds
WO2009053443A2 (en) Indane compounds
EP3150598B1 (en) Substituted tropane derivatives
HK1145680A (en) Phenylpyrrolidine compounds
HK1145327A (en) Compounds of 2,3-dihydro-benzofuran
HK1145679A (en) Indoline compounds
WO2025113520A1 (zh) 酰胺类化合物及其用途

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20131023